Safety Update

Author:

Joyner Michael J.ORCID,Bruno Katelyn A.ORCID,Klassen Stephen A.ORCID,Kunze Katie L.ORCID,Johnson Patrick W.ORCID,Lesser Elizabeth R.ORCID,Wiggins Chad C.ORCID,Senefeld Jonathon W.ORCID,Klompas Allan M.ORCID,Hodge David O.ORCID,Shepherd John R.A.ORCID,Rea Robert F.,Whelan Emily R.ORCID,Clayburn Andrew J.ORCID,Spiegel Matthew R.,Baker Sarah E.ORCID,Larson Kathryn F.ORCID,Ripoll Juan G.ORCID,Andersen Kylie J.ORCID,Buras Matthew R.ORCID,Vogt Matthew N.P.ORCID,Herasevich VitalyORCID,Dennis Joshua J.ORCID,Regimbal Riley J.ORCID,Bauer Philippe R.ORCID,Blair Janis E.ORCID,van Buskirk Camille M.,Winters Jeffrey L.ORCID,Stubbs James R.ORCID,van Helmond NoudORCID,Butterfield Brian P.,Sexton Matthew A.ORCID,Diaz Soto Juan C.ORCID,Paneth Nigel S.ORCID,Verdun Nicole C.,Marks PeterORCID,Casadevall ArturoORCID,Fairweather DeLisaORCID,Carter Rickey E.ORCID,Wright R. Scott

Funder

U.S. Department of Health and Human Services

Biomedical Advanced Research and Development Authority

National Center for Advancing Translational Sciences

National Heart, Lung, and Blood Institute

National Institute of Diabetes and Digestive and Kidney Diseases

Natural Sciences and Engineering Research Council of Canada

National Institute of Allergy and Infectious Disease

National Institute on Aging

Schwab Charitable

Wentworth

Executive Dean of Research at Mayo Clinic

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19): cases in US. CDC website. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html. Accessed August 4, 2020.

2. The many estimates of the COVID-19 case fatality rate;Rajgor;Lancet Infect Dis,2020

3. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study;Yang;Lancet Respir Med,2020

4. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area;Richardson;JAMA,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3